A Randomized, Double Blind, Placebo Controlled Trial L-carnitine and Piracetam in the Treatment of Weakness, Muscle Fatigue and Muscle Pain in the Postpoliomyelitis Syndrome

Postpoliomyelitis Syndrome Clinical Trial

Official title:
A Phase III, Randomized, Double Blind, Placebo Controlled Trial to Evaluate the Therapeutic Effect of the Association of L-carnitine and Piracetam as an Adjuvant Therapy in the Treatment of Weakness, Muscle Fatigue and Muscle Pain in the Postpoliomyelitis Syndrome

Status Withdrawn

Clinical Trial Summary

This protocol aims to assess of L-carnitine and piracetam to relieve weakness, muscle fatigue and muscle pain in patients with Postpoliomyelitis Syndrome.

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT01549847
Study type	Interventional
Source	Biolab Sanus Farmaceutica
Contact
Status	Withdrawn
Phase	Phase 3

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05663008` - Impairments of Neuro-muscular Communication in Motor-Neuron Disease: A Bio-Marker for Early and Personalised Diagnosis
Completed	`NCT00001185` - Study of "Post-Polio Syndrome"	N/A
Recruiting	`NCT06320444` - Non-invasive Spinal, Cortical, and Sensorimotor Biomarkers in Motor Neurone Disease
Completed	`NCT01271530` - Arm Cycling to Improve Fitness in Polio Survivors	N/A
Completed	`NCT00004553` - Electromyography to Diagnose Neuromuscular Disorders	N/A
Terminated	`NCT00067496` - Modafinil to Treat Fatigue in Post-Polio Syndrome	Phase 3